Clinical Trial Update: The Role of MSC in the Treatment of Fistulas in Patients With Perianal Crohn's Disease [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 2/Phase 3 study evaluating mesenchymal stem cell therapy for fistulas in patients with perianal Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Fistula

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Crohn's Disease, Fistula | Phase 2, Phase 3 | Status: UNKNOWN